Future bleak for Arcadia as cash crunch forces sale of business unit
Indianapolis-based Arcadia Resources Inc.’s auditor issued a “going-concern” warning Tuesday in the once-promising company’s annual report.
Indianapolis-based Arcadia Resources Inc.’s auditor issued a “going-concern” warning Tuesday in the once-promising company’s annual report.
Baldwin & Lyons Inc. expects to lose another $10 million due to worldwide catastrophes that occurred in the first half of the year, the Indianapolis-based property and casualty insurer reported Tuesday.
Indiana's attorney general has appealed a judge's decision blocking part of new abortion law that took away some of the public funding for Planned Parenthood of Indiana.
As part of its agreement to add Westview Hospital to its system, Community Health Network will assume $10 million in debt, spend $7.5 million on upgrades, and help open an outpatient center in Speedway, the two hospitals announced Tuesday morning.
Indianapolis-based drugmaker Eli Lilly on Tuesday will announce a multimillion-dollar investment to develop drugs that act like two medicines in one. Lilly plans to add more scientists to back the effort.
Jim Alender has been CEO of Howard Regional Health System in Kokomo since 1997. He recently negotiated a letter of intent to merge the hospital with Indianapolis-based Indiana University Health. He spoke about the major factors that led to that decision, and the benefits he hopes to come from it. The deal, which still requires approval from Howard County officials, could close before the end of this year.
Help with physician recruitment is a big factor pushing small-city hospitals into the arms of Indianapolis’ four major hospital systems. So how do the big boys entice doctors to the small towns?
The U.S. Supreme Court has refused to revive a bid to press a $6.8 billion class-action suit against Eli Lilly and Co. over the marketing of Zyprexa, the company’s schizophrenia treatment.
Eli Lilly and Co., Amylin Pharmaceuticals Inc. and Alkermes Inc. said an analysis of a 148-patient trial found no evidence that their experimental Bydureon diabetes drug causes prolonged heart rhythms.
Planned Parenthood of Indiana expects to resume offering services to Medicaid patients following a judge's ruling that the state is not allowed to cut off the organization's public funding for general health services solely because it also provides abortions.
Eli Lilly and Co. and Boehringer Ingelheim GmbH’s Trajenta medicine for Type 2 diabetes has been recommended for approval in Europe, putting the drug on track to enter the region’s market this year.
Health insurer WellPoint Inc. has enlisted Google Maps for new websites that help patients think twice before they visit an emergency room for care that a less-expensive retail health clinic could handle.
Tomisue Hilbert quietly settled a 3-year-old lawsuit last month over whether a controversial life insurance policy issued in 2006 on her mother, Suzy Tomlinson, was valid, and whether the beneficiary of the policy, J.B. Carlson, committed fraud.
The U.S. government needs to open its borders to attract and retain talented scientists for drugmakers to employ, Eli Lilly & Co. CEO John Lechleiter plans to tell a technology conference Thursday.
A total of 220 life sciences startups have been launched in Indiana since 2004, or an average of 44 per year, according to a new report from BioCrossroads that tracked the industry’s growth over the last eight years.
Citizens Action Coalition Education Fund and Indiana Legal Services Inc. claim that “a good number” of Indianapolis south-side residents who should have qualified for reduced or waived bills at St. Francis were instead steered into payments plans.
Wishard Health Services will change its name to Eskenazi Health after receiving a $40 million gift from Indianapolis real estate developer Sidney Eskenazi and his wife Lois, the county-owned hospital announced Wednesday morning.
Anthem Blue Cross, an affiliate of WellPoint Inc., has agreed to settle a lawsuit that accused the health insurer of manipulating policies and forcing patients into higher deductible policies with fewer benefits.
European Union regulators have approved the first once-per-week diabetes medication, the companies that developed the drug said Tuesday.
Planned Parenthood of Indiana is no longer seeing Medicaid patients because a federal judge hasn't ruled yet on its attempt to block a new Indiana law cutting funding for certain abortion providers, officials said Monday.